All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic.
Cohort study
Epidemiology
SARS
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
14
03
2023
accepted:
21
04
2023
medline:
8
5
2023
pubmed:
5
5
2023
entrez:
4
5
2023
Statut:
ppublish
Résumé
To investigate all-cause mortality, COVID-19 mortality and all-cause non-COVID-19 mortality in Qatar during the COVID-19 pandemic. A national, retrospective cohort analysis and national, matched, retrospective cohort studies were conducted between 5 February 2020 and 19 September 2022. There were 5025 deaths during a follow-up time of 5 247 220 person-years, of which 675 were COVID-19 related. Incidence rates were 0.96 (95% CI 0.93 to 0.98) per 1000 person-years for all-cause mortality, 0.13 (95% CI 0.12 to 0.14) per 1000 person-years for COVID-19 mortality and 0.83 (95% CI 0.80 to 0.85) per 1000 person-years for all-cause non-COVID-19 mortality. Adjusted HR, comparing all-cause non-COVID-19 mortality relative to Qataris, was lowest for Indians at 0.38 (95% CI 0.32 to 0.44), highest for Filipinos at 0.56 (95% CI 0.45 to 0.69) and was 0.51 (95% CI 0.45 to 0.58) for craft and manual workers (CMWs). Adjusted HR, comparing COVID-19 mortality relative to Qataris, was lowest for Indians at 1.54 (95% CI 0.97 to 2.44), highest for Nepalese at 5.34 (95% CI 1.56 to 18.34) and was 1.86 (95% CI 1.32 to 2.60) for CMWs. Incidence rate of all-cause mortality for each nationality group was lower than the crude death rate in the country of origin. Risk of non-COVID-19 death was low and was lowest among CMWs, perhaps reflecting the healthy worker effect. Risk of COVID-19 death was also low, but was highest among CMWs, largely reflecting higher exposure during first epidemic wave, before advent of effective COVID-19 treatments and vaccines.
Identifiants
pubmed: 37142299
pii: bmjgh-2023-012291
doi: 10.1136/bmjgh-2023-012291
pmc: PMC10163334
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: AAB has received institutional grant funding from Gilead Sciences unrelated to the work presented in this paper.
Références
N Engl J Med. 2021 Dec 9;385(24):e83
pubmed: 34614327
PLoS One. 2021 Oct 26;16(10):e0259152
pubmed: 34699571
PLoS Med. 2021 Dec 16;18(12):e1003879
pubmed: 34914711
Sci Rep. 2021 Jan 19;11(1):1811
pubmed: 33469048
Ann Intern Med. 2020 Dec 15;173(12):1004-1007
pubmed: 32915654
BMJ Open. 2020 Oct 7;10(10):e040428
pubmed: 33033033
PLoS One. 2022 Jul 19;17(7):e0271324
pubmed: 35853026
N Engl J Med. 2022 May 12;386(19):1804-1816
pubmed: 35263534
Nat Commun. 2022 Jun 2;13(1):3082
pubmed: 35654888
N Engl J Med. 2022 Jul 7;387(1):21-34
pubmed: 35704396
Nat Med. 2021 Dec;27(12):2136-2143
pubmed: 34728831
Injury. 2015 Sep;46(9):1806-13
pubmed: 25943291
PLoS One. 2017 Jun 20;12(6):e0179711
pubmed: 28632794
N Engl J Med. 2022 Oct 27;387(17):1620-1622
pubmed: 36198139
Int J Infect Dis. 2022 Nov;124:96-103
pubmed: 36218031
Sci Rep. 2021 Sep 14;11(1):18182
pubmed: 34521903
Int J Inj Contr Saf Promot. 2005 Mar;12(1):45-7
pubmed: 15814375
World J Surg. 2018 May;42(5):1346-1357
pubmed: 29063224
Open Forum Infect Dis. 2021 May 02;8(8):ofab221
pubmed: 34458388
Emerg Infect Dis. 2021 May;27(5):1343-1352
pubmed: 33900174
Diabetes Res Clin Pract. 2018 Mar;137:100-108
pubmed: 29175341
Occup Med (Lond). 1999 May;49(4):225-9
pubmed: 10474913
Lancet Infect Dis. 2023 Mar 10;:
pubmed: 36913963
Nat Commun. 2022 Aug 9;13(1):4675
pubmed: 35945213
Sci Rep. 2021 Mar 18;11(1):6233
pubmed: 33737535
EClinicalMedicine. 2021 May;35:100861
pubmed: 33937733
iScience. 2021 Jun 25;24(6):102646
pubmed: 34056566
J Glob Health. 2021 Jan 16;11:05005
pubmed: 33643638
Cardiology. 2019;143(1):37-48
pubmed: 31302648
N Engl J Med. 2021 Dec 30;385(27):2585-2586
pubmed: 34910864
BMJ Open Diabetes Res Care. 2022 Apr;10(2):
pubmed: 35443971
N Engl J Med. 2023 Feb 16;388(7):665-667
pubmed: 36652342
Popul Health Metr. 2019 Dec 30;17(1):20
pubmed: 31888689
World J Pediatr. 2011 Feb;7(1):41-4
pubmed: 20549413
J Epidemiol Glob Health. 2014 Dec;4(4):277-87
pubmed: 25455645
BMC Public Health. 2020 Jul 29;20(1):1186
pubmed: 32727594